Alerts

Heart Risk and Death 44% Greater for Women with Diabetes See this week’s Item #1.

FDA: No evidence to support the general use of aspirin to prevent primary heart attacks and strokes. See this week’s Item #4.

FDA Safety Communication: Shasta Technologies GenStrip Blood Glucose Test Strips May Report False Results The FDA is advising people with diabetes and health care professionals to stop using GenStrip Blood Glucose Test Strips because the strips may report incorrect blood glucose levels. The FDA recommends the use of alternative glucose …

Nationwide IV Fluid Shortage Threatens Care (JAMA) 

Actos Generic Available Shortly from Lupin – Lupin has announced that it received final approval from the FDA for pioglitazone tablets USP in 15-mg, 30-mg and 45-mg strengths. The product is the generic version of Actos tablets from Takeda Pharmaceuticals. Albiglutide, Weekly Injectable GLP-1 Drug, Receives FDA Approval –  (See this week’s Item #6.) 

Afrezza Inhaled Insulin Approved by FDA Panel for Type 1 and Type 2 Diabetes See our feature article, FDA Panel Approves Inhaled Insulin, Again.

House Votes to Delay Medicare Pay Cut and ICD-10 Rollout.

FDA MedWatch: FreeStyle and FreeStyle Flash Blood Glucose Meter by Abbott Recall May produce mistakenly low blood glucose results including the OmniPod Insulin Management System with the built-in FreeStyle Blood Glucose Meter. For more information.

New Global Sugar Intake Guideline Needs Your Input See this week’s Item #1.

FDA Denies Empagliflozin Approval (See this week’s Item #8.) Bydureon Pen Approved (See this week’s Item #3.)